Immediate Impact

1 by Nobel laureates 6 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
E-cadherin is required for metastasis in multiple models of breast cancer
2019 StandoutNature
8 intermediate papers

Works of James E. Hunter being referenced

Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
2009
Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma
1992

Author Peers

Author Last Decade Papers Cites
James E. Hunter 332 13 74 177 106 25 539
Yoshiyuki Fukushi 141 36 129 170 40 491
Masaomi Takayama 134 21 107 127 32 479
Shinji Sato 248 96 252 177 28 613
Tatsuo Yagyu 99 28 39 200 21 469
Guiling Li 91 88 103 119 38 495
Rébécca Phaëton 52 72 72 254 28 592
Tami Ueda 167 8 111 299 21 544
Xiaowen Tong 112 31 78 241 35 529
J. Rebecca Liu 84 25 80 313 18 538
Lai‐Fong Kok 45 40 81 172 21 465

All Works

Loading papers...

Rankless by CCL
2026